Should I Buy CRL Stock in 2026?
Data-driven analysis and honest assessment for Charles River Laboratories
Current Price: $218.82
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
P/E data not available
Declining -0%
Currently unprofitable
Financial health data limited
Strong FCF yield of 5.7%
No recent insider activity
Key Investment Metrics
Current Price
$218.82
P/E Ratio
N/A
Revenue Growth
-0.0%
Profit Margin
-0.0%
Market Cap
$10.9B
Dividend Yield
None
How CRL Compares to Competitors
Understanding how CRL stacks up against peers helps inform your investment decision.
How CRL Compares to Peers
Upcoming Events for CRL
+5 Reasons TO Buy CRL
1. High free cash flow yield of 5.7%
moderateFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
-5 Reasons NOT to Buy CRL
1. Company is not profitable
high riskCurrently losing money. May need to raise capital or cut operations.
2. Revenue declining 0%
medium riskShrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.
Who Should Buy CRL?
Investment Profile
Risk Level
Very High
Recommended Holding Period
5+ years (turnaround required)
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited -0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
Consider These Alternatives
If you're interested in CRL, compare these Healthcare peers:
Pro tip: Compare CRL directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for CRL
Frequently Asked Questions
What is CRL stock price today?
CRL (Charles River Laboratories) stock is trading at $218.82 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is CRL stock going up or down today?
CRL stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy CRL stock now?
The decision to buy CRL depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is CRL a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for CRL based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is CRL stock overvalued or undervalued?
Use our DCF valuation calculator to determine if CRL is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is CRL's P/E ratio?
P/E ratio data for CRL will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is CRL's market cap?
CRL (Charles River Laboratories) has a market capitalization of $10.87 billion, making it a mid-cap stock.
What is CRL's price to book ratio?
CRL trades at a price-to-book (P/B) ratio of 3.19, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Charles River Laboratories
Full Stock Analysis
Complete CRL overview with charts and data
Is CRL Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how CRL stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Charles River Laboratories
Complete CRL Analysis
Compare CRL With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.